HipecTreatment Banner
Doctor: Jason Foster, M.D. Director of Peritoneal Surface Malignancy Program at University of Nebraska Medical Center, Omaha, Nebraska
Hospital: UNIVERSITY OF NEBRASKA MEDICAL CENER, Omaha, NE
Webinar: Hyperthermic Intraperitoneal Hyperthermia (HIPEC) from a Patient Perspective and from the Surgeon's Perspective
Surgeon's Perspective: Dr. Foster discusses rationale for treatment of Peritoneal/Abdominal Cancer from Advanced Colon Cancer, Appendiceal Cancer, Pseudomyxoma Peritonei (PMP) and Ovarian Cancer with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), patient selection and the surgical technique.



Patient's Perspective: A panel of patients who were diagnosed with Peritoneal/Abdominal Cancer from Advanced Colon Cancer, Appendiceal Cancer or Pseudomyxoma Peritonei (PMP) and were treated with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) discuss this treatment option from the patient's perspective. (coming soon)